Tag: NYSEARCA:UNG

  • Unusual Volume: Bank of America (NYSE:BAC), Comcast Corporation (NASDAQ:CMCSA), United States Natural Gas Fund (NYSEARCA:UNG), Chelsea Therapeutics International (NASDAQ:CHTP)

    Bank of America Corp (NYSE:BAC) boosted Chief Executive Brian Moynihan ‘s salary and bonus 17% to $14 million for 2013, rewarding its top executive for a year in which the bank posted its strongest annual profit since 2007. The second largest U.S. lender by assets paid its CEO $1.5 million in salary and $12.5 million in restricted shares, according to a regulatory filing Wednesday evening and a proxy statement from last year. The payout is Mr. Moynihan’s largest since he took over the Charlotte, N.C., company in 2010. Bank of America Corp (NYSE:BAC) stock opened at $16.38 in last trading session, and closed at $16.20, trading in the range of $16.18 – $16.45. The stock showed a negative weekly performance of -4.03%.

    TheStreet restated their buy rating on shares of Comcast Corp. (NASDAQ:CMCSA) in a report issued on Tuesday, Analyst Ratings Net reports. Comcast Corporation (NASDAQ:CMCSA) shares closed at $51.57 on last trade day, by losing -3.66%. Stock 52 week range is $38.75 – $55.28. Company’s market capitalization is $134.42 billion.

    Another day, another violent move in the price of natural gas, with the commodity’s most actively traded futures contract surging 7% Wednesday morning. A much-anticipated inventory report tomorrow is expected to show another large reduction in the country’s natural-gas stockpile, which is one key reason for the heavy interest Wednesday. United States Natural Gas Fund, LP (NYSEARCA:UNG), the futures-market tracker with the long-term downtrend, is at a fresh two-year high this morning. The ETF is ahead by 2.6% to $26.87 in recent trading. United States Natural Gas Fund, LP (NYSEARCA:UNG) stock advanced 2.86% and finished the last session at $26.95. The EPS of the stock remained -2.74. Company’s market capitalization is $920.79 million.

    Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) is set to introduce its first product in the market as its drug wins U.S. approval. The drug is targeted at prevention of sudden drops in blood pressure. Northera aims at treating patients with nervous system disorders caused due to the sudden fall in blood pressure level, said the Food and Drug Administration in a statement. The drop of blood pressure also causes fainting and dizziness in such patients. The director of the division of Cardiovascular and Renal Drugs in the FDA’s Center for Drug Evaluation and Research, Norman Stockbridge further said that those suffering from neurogenic orthostatic hypotension face difficulties in carrying out their everyday activities which require standing or walking. Commenting on the limited treatment options available for NOH, he said that FDA is committed to come up with safe and effective treatments. Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) stock opened at $6.65 in last trading session and closed at $6.16. The 52 week range of the stock is $0.76 – $6.83 and the day range was $5.95 – $6.83.